13F filer · CIK 315066 ↗
Fidelity Investments
You are looking at Q3 2017. See the latest, Q2 2026 →
Reported value
$827.12B
+2.8% on the quarter before
Positions
2,590
128 new · 145 sold out
Top 10
17.6%
of the value
Est. gain
+$37.75B
on stocks held all quarter
Est. return
+5.1%
on those stocks since Q2 2017
Positions as of Sep 30, 2017, from Fidelity Investments's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2017. Striped tiles are options.
Largest buys
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Dowdupont Inc~$4.00BNew · 0.0% → 0.5%+57,792,499 shares
- British Amern Tob Plc~$721.9MAdded · 0.2% → 0.3%+11,560,132 shares
- Celgene Corp~$691.2MAdded · 0.2% → 0.3%+4,740,190 shares
- Becton Dickinson & Co~$681.3MAdded · 0.2% → 0.2%+3,477,135 shares
- Baker Hughes~$670.5MNew · 0.0% → 0.1%+18,309,847 shares
- Schein Henry Inc~$495.9MAdded · 0.2% → 0.1%+6,047,928 shares
- Thermo Fisher Scientific Inc~$485.8MAdded · 0.1% → 0.1%+2,567,657 shares
- Smucker J M Co~$460.1MAdded · 0.0% → 0.1%+4,385,102 shares
- Mcdonalds Corp~$409.5MAdded · 0.2% → 0.2%+2,613,518 shares
- Amgen Inc~$379.9MAdded · 1.2% → 1.3%+2,037,486 shares
Largest sells
Since Q2 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Du Pont E I De Nemours & Co~$2.75BSold out · 0.3% → 0.0%−34,026,342 shares
- Apple~$1.80BCut · 2.8% → 2.7%−11,675,400 shares
- Baker Hughes Inc~$1.26BSold out · 0.2% → 0.0%−23,194,134 shares
- Medtronic Plc~$1.17BCut · 0.6% → 0.3%−15,015,381 shares
- Charter Communications Inc N~$1.08BCut · 0.4% → 0.3%−2,984,924 shares
- Reynolds American Inc~$914.0MSold out · 0.1% → 0.0%−14,053,162 shares
- Dow Chem Co~$885.4MSold out · 0.1% → 0.0%−14,038,881 shares
- Qualcomm~$880.1MCut · 0.6% → 0.4%−16,977,989 shares
- Walt Disney Company (The)~$879.5MCut · 0.4% → 0.3%−8,922,880 shares
- Activision Blizzard Inc~$752.9MCut · 0.8% → 0.8%−11,670,611 shares
Holdings
As of Sep 30, 2017. Changes are in shares against Jun 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AppleCOM · shares −7.4% · price +7.0% | 2.7% | $22.42B | +$1.47B | ||||||||
| MetaCL A · shares −1.5% · price +13.2% | 2.7% | $22.13B | +$2.58B | ||||||||
| AmazonCOM · shares −2.5% · price −0.7% | 2.1% | $17.32B | −$119.8M | ||||||||
| AlphabetCAP STK CL A · shares −1.0% · price +4.7% | 2.1% | $17.00B | +$769.1M | ||||||||
| MicrosoftCOM · shares +1.6% · price +8.1% | 1.6% | $13.10B | +$962.8M | ||||||||
| AlphabetCAP STK CL C · shares −4.2% · price +5.5% | 1.6% | $12.84B | +$674.5M | ||||||||
| Unitedhealth Group IncCOM · shares +2.0% · price +5.6% | 1.4% | $11.21B | +$585.1M | ||||||||
| Amgen IncCOM · shares +3.6% · price +8.3% | 1.3% | $11.01B | +$810.5M | ||||||||
| NvidiaCOM · shares −4.7% · price +23.7% | 1.1% | $9.18B | +$1.76B | ||||||||
| Visa Inc.COM CL A · shares −0.5% · price +12.2% | 1.1% | $9.09B | +$989.6M | ||||||||
| Jpmorgan Chase & CoCOM · shares −2.2% · price +4.5% | 1.1% | $8.90B | +$382.8M | ||||||||
| Bank Amer CorpCOM · shares −2.4% · price +4.5% | 1.00% | $8.23B | +$350.9M | ||||||||
| Berkshire Hathaway Inc DelCL A · shares +0.05% · price +7.9% | 0.97% | $8.04B | +$586.0M | ||||||||
| SalesforceCOM · shares +0.1% · price +7.9% | 0.95% | $7.89B | +$575.1M | ||||||||
| Citigroup IncCOM NEW · shares −1.3% · price +8.8% | 0.95% | $7.89B | +$635.3M | ||||||||
| Wells Fargo Co NewCOM · shares +0.03% · price −0.5% | 0.87% | $7.16B | −$33.8M | ||||||||
| TeslaCOM · shares −8.5% · price −5.7% | 0.80% | $6.66B | −$400.3M | ||||||||
| Activision Blizzard IncCOM · shares −11% · price +12.1% | 0.77% | $6.40B | +$689.0M | ||||||||
| PayPalCOM · shares +5.3% · price +19.3% | 0.67% | $5.55B | +$852.3M | ||||||||
| MastercardCL A · shares −2.2% · price +16.3% | 0.66% | $5.45B | +$761.7M | ||||||||
| AdobeCOM · shares +1.3% · price +5.5% | 0.65% | $5.39B | +$275.9M | ||||||||
| Boston Scientific CorpCOM · shares +2.6% · price +5.2% | 0.63% | $5.21B | +$252.7M | ||||||||
| Home Depot IncCOM · shares −5.4% · price +6.6% | 0.60% | $4.98B | +$309.5M | ||||||||
| AlibabaSPONSORED ADS · shares +5.7% · price +22.6% | 0.56% | $4.61B | +$804.1M | ||||||||
| NetflixCOM · shares +2.0% · price +21.4% | 0.53% | $4.37B | +$754.8M | ||||||||
| Total · 2,590 positions | 100% | $827.12B | +$37.75B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2017 to Q3 2017: 2,397 stocks held throughout, up $37.75B (+5.1%).
- Meta+$2.58B+13%
- Nvidia+$1.76B+24%
- Apple+$1.47B+7%
- Visa Inc.+$989.6M+12%
- Microsoft+$962.8M+8%
- Tesla−$400.3M−6%
- Medtronic Plc−$401.7M−12%
- Teva Pharmaceutical Inds Ltd−$407.8M−47%
- Allergan Plc−$506.7M−16%
- Schein Henry Inc−$699.3M−55%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 13, 2026 | $2.30T+21% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.90T−3% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $1.96T+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $1.92T+8% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $1.77T+13% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $1.57T−7% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $1.68T+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $1.64T+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $1.56T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.49T+14% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $1.30T+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $1.16T−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $1.19T−45% | SEC ↗ |
| Q1 2023 | May 11, 2023 (amended) | $2.19T+117% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $1.01T+5% | SEC ↗ |
| Q3 2022 | Nov 10, 2022 | $958.93B−4% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $1.00T−20% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $1.25T−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $1.35T+7% | SEC ↗ |
| Q3 2021 | Feb 14, 2022 (amended) | $1.26T−1% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $1.28T+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $1.17T+4% | SEC ↗ |
| Q4 2020 | Feb 8, 2021 | $1.12T+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $989.33B+9% | SEC ↗ |
| Q2 2020 | Aug 24, 2020 (amended) | $909.48B+26% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $722.13B−20% | SEC ↗ |
| Q4 2019 | Feb 7, 2020 | $906.40B+9% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $833.77B−3% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $856.19B+3% | SEC ↗ |
| Q1 2019 | May 13, 2019 (amended) | $834.93B+14% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $730.25B−18% | SEC ↗ |
| Q3 2018 | Nov 9, 2018 | $888.88B+2% | SEC ↗ |
| Q2 2018 | Aug 10, 2018 (amended) | $868.68B+3% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $842.35B−1% | SEC ↗ |
| Q4 2017 | Feb 12, 2018 | $853.06B+3% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $827.12B+3% | SEC ↗ |
| Q2 2017 | Aug 29, 2017 (amended) | $804.55B+2% | SEC ↗ |
| Q1 2017 | May 11, 2017 | $787.10B+5% | SEC ↗ |
| Q4 2016 | Feb 10, 2017 (amended) | $748.25B−0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $750.86B+2% | SEC ↗ |
| Q2 2016 | Aug 11, 2016 | $732.58B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $722.80B | SEC ↗ |